Cargando…
Repurposing ferumoxytol: Diagnostic and therapeutic applications of an FDA-approved nanoparticle
Ferumoxytol is an intravenous iron oxide nanoparticle formulation that has been approved by the U.S. Food and Drug Administration (FDA) for treating anemia in patients with chronic kidney disease. In recent years, ferumoxytol has also been demonstrated to have potential for many additional biomedica...
Autores principales: | Huang, Yue, Hsu, Jessica C., Koo, Hyun, Cormode, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692919/ https://www.ncbi.nlm.nih.gov/pubmed/34976214 http://dx.doi.org/10.7150/thno.67375 |
Ejemplares similares
-
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
por: Trujillo-Alonso, Vicenta, et al.
Publicado: (2019) -
Repurposing FDA-approved drugs for anti-aging therapies
por: Snell, Terry W., et al.
Publicado: (2016) -
Repurposing of FDA-approved drugs against cancer – focus on metastasis
por: Ozsvári, Béla, et al.
Publicado: (2016) -
Topical ferumoxytol nanoparticles disrupt biofilms and prevent tooth decay in vivo via intrinsic catalytic activity
por: Liu, Yuan, et al.
Publicado: (2018) -
Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
por: Benedict, Ashwini, et al.
Publicado: (2015)